Optimal Surveillance of Metachronous Gastric Lesion after Endoscopic Resection of Early Gastric Cancer
4
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Endoscopic resection (ER)–a minimal invasive procedure, compared to surgical gastrectomy, with the advantage of preserving the entire stomach and maintaining the patient’s quality of life–is a widely used curative treatment for early gastric cancers (EGCs). Despite its advantages, such as the preservation of the whole stomach, a large area of the gastric mucosa with histologic changes such as atrophy and intestinal metaplasia remains after ER, and so does the risk of metachronous gastric cancers (MGCs). Therefore, regular surveillance endoscopy after curative ER of EGCs is important so that MGCs are detected early and so minimally invasive ER remains a treatment option. To date, the optimal interval for surveillance endoscopy after curative ER of EGCs has not been established. Therefore, this review summarizes the results of the published studies on this topic with the aim of establishing the optimal surveillance interval for early identification of MGCs. Based on my review, the median timing of MGC occurrence is within 3 years, and reports suggest biannual endoscopy during the first 3 years; however, the evidence suggests that individual patient characteristics may influence the risk of MGCs. Therefore, stratified endoscopic strategies for surveillance based on patient characteristics, such as age, family history of gastric cancer, synchronous gastric lesions, and corpus intestinal metaplasia, should be applied.
Abstract
Endoscopic resection (ER)–a minimal invasive procedure, compared to surgical gastrectomy, with the advantage of preserving the entire stomach and maintaining the patient’s quality of life–is a widely used curative treatment for early gastric cancers (EGCs). Despite its advantages, such as the preservation of the whole stomach, a large area of the gastric mucosa with histologic changes such as atrophy and intestinal metaplasia remains after ER, and so does the risk of metachronous gastric cancers (MGCs). Therefore, regular surveillance endoscopy after curative ER of EGCs is important so that MGCs are detected early and so minimally invasive ER remains a treatment option. To date, the optimal interval for surveillance endoscopy after curative ER of EGCs has not been established. Therefore, this review summarizes the results of the published studies on this topic with the aim of establishing the optimal surveillance interval for early identification of MGCs. Based on my review, the median timing of MGC occurrence is within 3 years, and reports suggest biannual endoscopy during the first 3 years; however, the evidence suggests that individual patient characteristics may influence the risk of MGCs. Therefore, stratified endoscopic strategies for surveillance based on patient characteristics, such as age, family history of gastric cancer, synchronous gastric lesions, and corpus intestinal metaplasia, should be applied.
참고문헌 (43)
- Sung H, "Global cancer statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries", CA Cancer J Clin, 71, pp.209~249 (2021)
- Kim GH, "Systematic endoscopic approach to early gastric cancer in clinical practice", Gut Liver, 15, pp.811~817 (2021)
- Lee MW, "Metachronous gastric cancer : another hurdle for successful endoscopic treatment for early gastric cancer?", Gut Liver, 14, pp.145~147 (2020)
- Abe S, "Long-term surveillance and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection", Endoscopy, 47, pp.1113~1118 (2015)
- Abe S, "Metachronous gastric cancer following curative endoscopic resection of early gastric cancer", Clin Endosc, 51, pp.253~259 (2018)
- Suk S, "The pattern of metachronous recurrence after endoscopic submucosal dissection for gastric adenocarcinoma and dysplasias", Clin Endosc, 56, pp.470~478 (2023)
- Ortigão R, "Risk factors for gastric metachronous lesions after endoscopic or surgical resection : a systematic review and meta-analysis", Endoscopy, 54, pp.892~901 (2022)
- Kato M, "Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer : a multicentre retrospective cohort study by Osaka University ESD study group", Gut, 62, pp.1425~1432 (2013)
- Ami R, "Factors associated with metachronous gastric cancer development after endoscopic submucosal dissection for early gastric cancer", J Clin Gastroenterol, 51, pp.494~499 (2017)
- Choe Y, "The optimal interval of surveillance gastroscopy after endoscopic resection for gastric neoplasia : a multicenter cohort study", Surg Endosc, 37, pp.7556~7562 (2023)
- Kwon Y, "Helicobacter pylori infection and serum level of pepsinogen are associated with the risk of metachronous gastric neoplasm after endoscopic resection", Aliment Pharmacol Ther, 46, pp.758~767 (2017)
- Suzuki H, "Long-term survival after endoscopic resection for gastric cancer : real-world evidence from a multicenter prospective cohort", Clin Gastroenterol Hepatol, 21, pp.307~318 (2023)
- Park CH, "Clinical practice guideline for endoscopic resection of early gastrointestinal cancer", Clin Endosc, 53, pp.142~166 (2020)
- Ono H, "Guidelines for endoscopic submucosal dissection and endoscopic mucosal resection for early gastric cancer(second edition)", Dig Endosc, 33, pp.4~20 (2021)
- Pimentel-Nunes P, "Endoscopic submucosal dissection for superficial gastrointestinal lesions : European Society of Gastrointestinal Endoscopy(ESGE)Guideline : update 2022", Endoscopy, 54, pp.591~622 (2022)
- Chung CS, "Risk factors for metachronous recurrence after endoscopic submucosal dissection of early gastric cancer", J Korean Med Sci, 32, pp.421~426 (2017)
- Mori G, "Incidence of and risk factors for metachronous gastric cancer after endoscopic resection and successful Helicobacter pylori eradication : results of a large-scale, multicenter cohort study in Japan", Gastric Cancer, 19, pp.911~918 (2016)
- Okada K, "Incidence of metachronous gastric cancer in patients whose primary gastric neoplasms were discovered after Helicobacter pylori eradication", Gastrointest Endosc, 89, pp.1152~1159 (2019)
- Correa P, "A human model of gastric carcinogenesis", Cancer Res, 48, pp.3554~3560 (1988)
- Fan F, "Effects of eradicating Helicobacter pylori on metachronous gastric cancer prevention : a systematic review and meta-analysis", J Eval Clin Pract, 26, pp.308~315 (2020)
- Xiao S, "Helicobacter pylori status and risks of metachronous recurrence after endoscopic resection of early gastric cancer : a systematic review and meta-analysis", J Gastroenterol, 54, pp.226~237 (2019)
- Kitamura Y, "Characteristic epithelium with low-grade atypia appears on the surface of gastric cancer after successful Helicobacter pylori eradication therapy", Helicobacter, 19, pp.289~295 (2014)
- Kobayashi M, "Magnifying narrow-band imaging of surface maturation in early differentiated-type gastric cancers after Helicobacter pylori eradication", J Gastroenterol, 48, pp.1332~1342 (2013)
- Kim SY, "Quality indicators in esophagogastroduodenoscopy", Clin Endosc, 55, pp.319~331 (2022)
- Pimenta-Melo AR, "Missing rate for gastric cancer during upper gastrointestinal endoscopy : a systematic review and metaanalysis", Eur J Gastroenterol Hepatol, 28, pp.1041~1049 (2016)
- Kim HH, "Causes of missed synchronous gastric epithelial neoplasms with endoscopic submucosal dissection : a multicenter study", Scand J Gastroenterol, 48, pp.1339~1346 (2013)
- Yoo JH, "How can we predict the presence of missed synchronous lesions after endoscopic submucosal dissection for early gastric cancers or gastric adenomas?", J Clin Gastroenterol, 47, pp.e17~e22 (2013)
- Nakajima T, "Metachronous gastric cancers after endoscopic resection : how effective is annual endoscopic surveillance?", Gastric Cancer, 9, pp.93~98 (2006)
- Min BH, "Surveillance strategy based on the incidence and patterns of recurrence after curative endoscopic submucosal dissection for early gastric cancer", Endoscopy, 47, pp.784~793 (2015)
- Cho CJ, "The incidence and locational predilection of metachronous tumors after endoscopic resection of high-grade dysplasia and early gastric cancer", Surg Endosc, 31, pp.389~397 (2017)
- Hahn KY, "Incidence and impact of scheduled endoscopic surveillance on recurrence after curative endoscopic resection for early gastric cancer", Gastrointest Endosc, 84, pp.628~638 (2016)
- Kim SJ, "Comparison of biannual and annual endoscopic gastric cancer surveillance after endoscopic resection", Surg Endosc, 36, pp.1806~1813 (2022)
- Ozeki Y, "Impact of endoscopy intervals on metachronous gastric cancer after endoscopic submucosal dissection : comparison between 1 year and halfa-year", Dig Endosc, 36, pp.332~340 (2024)
- Yasuda T, "Risk and prognostic factors of invasive gastric cancer detection during surveillance endoscopy : multi-institutional cross-sectional study", Dig Endosc, 35, pp.592~602 (2023)
- Yoshida M, "Second gastric cancer after curative endoscopic resection of differentiatedtype early gastric cancer : post-hoc analysis of a single-arm confirmatory trial", Gastrointest Endosc, 95, pp.650~659 (2022)
- Li WQ, "Beneficial effects of endoscopic screening on gastric cancer and optimal screening interval : a population-based study", Endoscopy, 54, pp.848~858 (2022)
- Park HJ, "2021 Korean Society of Gastrointestinal Endoscopy Clinical Practice Guidelines for endoscopic sedation", Gut Liver, 16, pp.341~356 (2022)
- Lee JM, "New sedatives and analgesic drugs for gastrointestinal endoscopic procedures", Clin Endosc, 55, pp.581~587 (2022)
- Rei A, "Metachronous lesions after gastric endoscopic submucosal dissection : first assessment of the FAMISH prediction score", Endoscopy, 55, pp.909~917 (2023)
- Tamura G, "Molecular characterization of undifferentiated-type gastric carcinoma", Lab Invest, 81, pp.593~598 (2001)
- Huh CW, "Endoscopic submucosal dissection versus surgery for undifferentiated-type early gastric cancer : a systematic review and meta-analysis", Clin Endosc, 54, pp.202~210 (2021)
- Ishioka M, "Incidence of metachronous cancer after endoscopic submucosal dissection : a comparison between undifferentiated-type and differentiated-type early gastric cancer", Gastrointest Endosc, 93, pp.557~564 (2021)
- Abe S, "Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer : Japan Clinical Oncology Group study-post hoc analysis of JCOG1009", 1010, 2021, pp.24, 1123~1130